Lymphoma Trial, Recruiting (NCT07443514)

Lymphoma Trial, Recruiting NCT07443514 Sponsor: Institute of Oncology Ljubljana Condition: Lymphoma

Printed from Voxsanity (voxsanity.com.au) — NCT07443514 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lymphoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults between the ages of 18 and 80 years old
People who have recently been diagnosed with a type of blood cancer called diffuse large B-cell lymphoma (DLBCL) and are planned to receive a standard chemotherapy treatment called R-CHOP, with or without chemotherapy injected into the spine
People who are able to sign a form agreeing to take part in the study
For a healthy comparison group: family members of patients already taking part in the trial who are willing to complete thinking and memory tests and answer questionnaires

Who may not be able to join:

People with severe memory or thinking difficulties that would prevent them from completing the study's cognitive tests
People with a serious mental health condition or brain/nervous system disease that would interfere with the thinking and memory assessments
People who are unable to understand the study procedures or complete the required questionnaires
People who are unwilling or unable to sign the consent form agreeing to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 031630065

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07443514

Sponsor: Institute of Oncology Ljubljana

Phase: Not Applicable

Status: Recruiting

Condition: Lymphoma

Trial contact: 031630065

More information: https://clinicaltrials.gov/study/NCT07443514

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults between the ages of 18 and 80 years old
People who have recently been diagnosed with a type of blood cancer called diffuse large B-cell lymphoma (DLBCL) and are planned to receive a standard chemotherapy treatment called R-CHOP, with or without chemotherapy injected into the spine
People who are able to sign a form agreeing to take part in the study
For a healthy comparison group: family members of patients already taking part in the trial who are willing to complete thinking and memory tests and answer questionnaires

Who may not be able to join:

People with severe memory or thinking difficulties that would prevent them from completing the study's cognitive tests
People with a serious mental health condition or brain/nervous system disease that would interfere with the thinking and memory assessments
People who are unable to understand the study procedures or complete the required questionnaires
People who are unwilling or unable to sign the consent form agreeing to take part

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Institute of Oncology Ljubljana

Registry

ClinicalTrials.gov

Start date

1 January 2022

Est. completion

31 December 2026

Where this trial is recruiting

🇸🇮 Slovenia

Primary endpoints

Cognitive Function (MoCA Total Score); Change in Cognitive Function (MoCA Total Score); Change in Cognitive Function (MoCA Total Score)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov